JP Morgan Private Wealth Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,500
Closed -$521K 1398
2016
Q4
$521K Buy
6,500
+2,240
+53% +$178K ﹤0.01% 790
2016
Q3
$340K Sell
4,260
-776
-15% -$62.6K ﹤0.01% 935
2016
Q2
$393K Buy
5,036
+1,078
+27% +$76.9K ﹤0.01% 871
2016
Q1
$218K Sell
3,958
-820
-17% -$44.7K ﹤0.01% 1050
2015
Q4
$295K Buy
4,778
+1,153
+32% +$72.7K ﹤0.01% 868
2015
Q3
$229K Sell
3,625
-4,044
-53% -$289K ﹤0.01% 894
2015
Q2
$560K Buy
7,669
+434
+6% +$31.4K 0.01% 637
2015
Q1
$473K Buy
7,235
+100
+1% +$6.65K 0.01% 742
2014
Q4
$464K Sell
7,135
-393
-5% -$25.3K 0.01% 735
2014
Q3
$454K Buy
7,528
+2,966
+65% +$194K 0.01% 719
2014
Q2
$316K Buy
+4,562
New +$296K 0.01% 703

Other funds holding STJ

JP Morgan Private Wealth Advisors's STJ Position: Q1 2017 in Review

JP Morgan Private Wealth Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,500 shares — an estimated $521K sold.

JP Morgan Private Wealth Advisors first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $560K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • JP Morgan Private Wealth Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 6,500 St Jude Medical shares in Q1 2017, an estimated $521K.
  • JP Morgan Private Wealth Advisors first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • JP Morgan Private Wealth Advisors's St Jude Medical position peaked at $560K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2017, filed 15 May 2017.